EVALUATION OF THE RELATIONSHIP BETWEEN HPV INFECTION RATE AND CYTOLOGY RESULTS IN WOMEN UNDERGOING CERVICAL CANCER SCREENING IN HANOI FROM 2022 TO 2023
Main Article Content
Abstract
Objectives: To determine the relationship between the prevalence of HPV genotypes and abnormal cervical cytology results in women undergoing cervical cancer screening. Methods: A cross-sectional descriptive study was conducted on 106 women undergoing screening at the Hanoi University Medical Hospital and the Military Medical Academy. These women exhibited abnormal cervical cytology results. Genotyping of the HPV gene was performed using Multiplex-PCR and Nested-PCR methods. Results: Among the 106 research subjects, 104 cases (98.1%) had cervical cell abnormalities, the most common being cervical intraepithelial neoplasia (CIN). When determining the HPV genotypes, we obtained 77 out of 106 positive results for HPV, with 66 cases positive for at least one HPV genotype. Of the 77 positive results, 60 cases (77.9%) were positive for high-risk HPV types, with HPV 16 being the most commonly detected type. Two cases were clinically diagnosed with squamous cell carcinoma (SCC) of the cervix and were positive for HPV 18 and HPV 11, respectively. We also detected 10 cases positive for HPV genotypes that were not included in the types surveyed. Conclusion: HPV 16 is the most prevalent genotype in samples of abnormal cervical cytology. Additionally, genotypes 18 and 11 were found in patients clinically diagnosed with SCC.
Article Details
Keywords
Cervical cancer, Abnormal cervical cytology, Human papillomavirus
References
2. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of Pathology. 1999; 189(1):12-19.
3. Phạm Thị Thanh Yên, Lưu Thị Hồng, Nguyễn Khánh Dương và CS. Tỷ lệ nhiễm Human Papilloma Virus ở phụ nữ đến khám tại Bệnh viện Phụ Sản Trung ương. Tạp chí Phụ sản. 2016; 14(1):125-128. https://doi.org/ 10.46755/vjog.2016.1.678.
4. Cox JT, Castle PE, Behrens CM, et al. Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: Results from the ATHENA HPV study. American Journal of Obstetrics and Gynecology. 2013; 208(3):184. e1-184. e11.
5. Nartey Y, Amo-Antwi K, Hill PC, et al. Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana. PloS one. 2023; 18(1):e0280437.
6. Ngô Thị Thanh Hương, Đào Thị Hoa, Lê Hoàng và CS. Nhiễm hpv nguy cơ cao trên bệnh nhân có tế bào âm đạo cổ tử cung bất thường tại Bệnh viện Phụ Sản Trung ương. Tạp chí Y học Việt Nam. 2021; 509(2). https://doi.org/10.51298/vmj.v509i2.1810.
7. Nguyễn Duy Ánh. Nghiên cứu tỷ lệ mắc HPV và một số yếu tố liên quan ở phụ nữ trong độ tuổi sinh sản ở Hà Nội. Tạp chí Y học Việt Nam. 04/25 2022; 512(1). DOI:10.51298/ vmj.v512i1.2218.
8. Wentzensen N. Triage of HPV-positive women in cervical cancer screening. The Lancet Oncology. 2013; 14(2):107-109.